Stryker Revenue Growth Rates (SYK), Current and Historic Growth - CSIMarket
CSIMarket
 


Stryker Corp  (NYSE: SYK)
 

SYK's Revenue Growth by Quarter and Year

Stryker's Revenue results by quarter and year




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/SYK/growth
https://api.csimarket.com/api/v1/companies/SYK/fundamentals
https://api.csimarket.com/api/v1/companies/SYK/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
SYK Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 6,520.00
2nd Quarter June 6,589.00
1st Quarter March 6,020.00
FY 19,129.00

SYKs Annual Revenue
Stryker's Revenue in the fiscal year 2025 $ 25,116.00 millions
Stryker's Revenue in the fiscal year 2024 $ 22,595.00 millions
Stryker's Revenue in the fiscal year 2023 $ 20,498.00 millions
Stryker's Revenue in the fiscal year 2022 $ 18,449.00 millions
Stryker's Revenue in the fiscal year 2021 $ 17,108.00 millions




SYK Revenue third quarter 2026 Y/Y Growth Comment
Stryker Corp reported Revenue growth of 7.64% year on year in the third quarter 2026, to $ 6,520.00 millions, this is lower than Stryker Corp's recent average Revenue growth of 9.06%.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 103 other companies have achieved higher Revenue growth. While Stryker Corp' s Revenue increase of 7.64% ranks overall at the positon no. 2034 in the third quarter 2026.




SYK Revenue ( Y/Y Growth %) 2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 7.64 %
2nd Quarter June 9.42 %
1st Quarter March 2.63 %
FY   -

Financial Statements
Stryker's third quarter 2026 Revenue $ 6,520.00 millions SYK's Income Statement
Stryker's third quarter 2025 Revenue $ 6,057.00 millions Quarterly SYK's Income Statement


SYK Revenue (Quarter on Quarter Growth %)

2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -1.05 %
2nd Quarter June 9.45 %
1st Quarter March -16.05 %
FY (Year on Year)   -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #104
Healthcare Sector #301
Overall #2034

Revenue Y/Y Growth Statistics
High Average Low
55.35 % 9.06 % -24.27 %
 
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #104
Healthcare Sector #301
Overall #2034
Revenue Y/Y Growth Statistics
High Average Low
55.35 % 9.06 % -24.27 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Stryker's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
35.2 % 2.46 % -22.97 %
(Sep 30 2020)  


SYK's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Stryker Corp disclosed decrease in Revenue from the second quarter by -1.05% to $ 6,520.00 millions, from $ 6,589.00 millions achived in the previous reporting period.

Although periodic circumstance commonly energize III. Quarter 2026 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 78 other companies have achieved higher Revenue quarter on quarter growth. While Stryker's Revenue growth quarter on quarter, overall rank is 2005.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #79
Healthcare Sector #253
Overall #2005
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #79
Healthcare Sector #253
Overall #2005
Revenue Q/Q Growth Statistics
High Average Low
35.2 % 2.46 % -22.97 %
(Sep 30 2020)  


SYK's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Stryker Corp disclosed decrease in Revenue from the second quarter by -1.05% to $ 6,520.00 millions, from $ 6,589.00 millions achived in the previous reporting period.

Although periodic circumstance commonly energize III. Quarter 2026 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 78 other companies have achieved higher Revenue quarter on quarter growth. While Stryker's Revenue growth quarter on quarter, overall rank is 2005.


Stryker's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)
12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 26,300.00
Y / Y Revenue Growth (TTM) 7.87 %
Year on Year Revenue Growth Overall Ranking # 1677
Seqeuential Revenue Change (TTM) 1.79 %
Seq. Revenue Growth (TTM) Overall Ranking # 1677


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2026 period, Stryker's cumulative twelve months Revenue were $ 26,300 millions, company would post below average annual Revenue growth of 1.79% year on year, if the fiscal year would end at Sep 30 2026.
A slow-down in the Stryker's Revenue growth from the 23818% growth in Jun 30 2026.

In the Healthcare sector 239 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1588 to 1677.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 90
Healthcare Sector # 240
Overall # 1417

Revenue TTM Y/Y Growth Statistics
High Average Low
19.21 %
8.8 %
-3.58 %
(Dec 31 2021)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 127
Sector # 343
S&P 500 # 2393
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2026 period, Stryker's cumulative twelve months Revenue were $ 26,300 millions, company would post below average annual Revenue growth of -3.58% year on year, if the fiscal year would end at Sep 30 2026.
A slow-down in the Stryker's Revenue growth from the 23818% growth in Jun 30 2026.

In the Healthcare sector 239 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1588 to 1677.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 90
Healthcare Sector # 240
Overall # 1417

Revenue TTM Y/Y Growth Statistics
High Average Low
19.21 %
8.8 %
-3.58 %
(Dec 31 2021)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 127
Sector # 343
S&P 500 # 2393




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SYK's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Neuronetics Inc 13.35%$ 13.350 millions
Royalty Pharma Plc13.26%$ 13.263 millions
Evolus Inc 13.23%$ 13.235 millions
Privia Health Group Inc 13.19%$ 13.187 millions
Biocryst Pharmaceuticals Inc 13.11%$ 13.110 millions
U S Physical Therapy Inc12.90%$ 12.898 millions
Maravai Lifesciences Holdings Inc 12.78%$ 12.781 millions
Alphatec Holdings Inc 12.67%$ 12.670 millions
Harmony Biosciences Holdings inc 12.61%$ 12.609 millions
Medicinova Inc 12.35%$ 12.355 millions
Bionano Genomics Inc 12.34%$ 12.339 millions
Viemed Healthcare Inc 12.18%$ 12.180 millions
Ufp Technologies Inc 12.15%$ 12.154 millions
Innovage Holding Corp 12.14%$ 12.135 millions
Vertex Pharmaceuticals Inc11.85%$ 11.845 millions
Sanara Medtech Inc 11.67%$ 11.668 millions
Lemaitre Vascular Inc 11.51%$ 11.508 millions
Pacs Group Inc 11.45%$ 11.454 millions
Ocugen Inc 11.36%$ 11.358 millions
Dexcom Inc 11.26%$ 11.263 millions
Elanco Animal Health Incorporated11.26%$ 11.258 millions
Koru Medical Systems Inc 11.19%$ 11.194 millions
Elite Pharmaceuticals Inc 11.11%$ 11.113 millions
Pro dex Inc 10.96%$ 10.955 millions
Nrc Health10.95%$ 10.954 millions
Anika Therapeutics Inc 10.91%$ 10.912 millions
Harvard Bioscience Inc 10.86%$ 10.864 millions
Repligen Corp10.86%$ 10.863 millions
Warby Parker Inc 10.77%$ 10.767 millions
Cerus Corporation10.69%$ 10.690 millions


About Stryker Revenue Growth Rates (SYK), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Stryker Corp (CIK 310764).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000310764-26-000061
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Stryker Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.